Suchergebnisse - "*Ritonavir"

PubPharm (8.378)

81

Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Yukishima, T. | Furuhashi, K. | Shimoyama, K. | +10

82

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19 : a retrospective cohort study

enthalten in: Scientific reports | 2024

von Chen, M. | Jiang, D. | Rang, J. | +2

83

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

84

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2024

von Brosh-Nissimov, T. | Ma'aravi, N. | Leshin-Carmel, D. | +5

85

Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Mizuno, T. | Kondo, Y. | Sakai, M. | +3

86

A Rare Cause of Acute Liver Failure

enthalten in: Gastroenterology | 2024

von Gibbens, Y. | Lake, J. | Lim, N.

87

Advanced 3D Electrospinning "Xspin" System : Fabrication of Bifiber Floating Oral Pharmaceutical Scaffolds for Controlled Drug Delivery

enthalten in: Molecular pharmaceutics | 2024

von Darwesh, A. | Zhang, Y. | Aghda, N. | +2

88

The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19

enthalten in: Pharmaceutics | 2024

von Bege, M. | Borbás, A.

89

Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

enthalten in: Infection | 2024

von Fernández-de-Las-Peñas, C. | Torres-Macho, J. | Catahay, J. | +8

ErratumIn: Infection. 2024 Mar 7;:. - PMID 38451416

90

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5